We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$18.6B
AUM Growth
+$370M
(+2%)
Cap. Flow
-$1.05B
Cap. Flow
% of AUM
-5.64%
Top 10 Holdings %
Top 10 Hldgs %
19.87%
Holding
1,286
New
95
Increased
394
Reduced
580
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.1M |
| 2 |
Amazon
AMZN
|
+$37.3M |
| 3 |
Agilent Technologies
A
|
+$34.9M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$34.7M |
| 5 |
Netflix
NFLX
|
+$33.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$132M |
| 2 |
Cencora
COR
|
+$65.6M |
| 3 |
Biogen
BIIB
|
+$53.3M |
| 4 |
Applied Materials
AMAT
|
+$44.9M |
| 5 |
Dollar General
DG
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.39% |
| 2 | Healthcare | 13.06% |
| 3 | Financials | 11.34% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
UGI
UGI
$7.87B
| $16.8M | 0.09% |
409,549
+105,845
| +35% | +$4.09M |
|
252
NeoGenomics
NEO
$1.99B
| $16.7M | 0.09% |
346,641
-86,077
| -20% | -$4.48M |
|
253
HealthEquity
HQY
$8.71B
| $16.7M | 0.09% |
245,532
-64,591
| -21% | -$5.07M |
|
254
TTM Technologies
TTMI
$10.6B
| $16.7M | 0.09% |
1,149,297
-301,328
| -21% | -$4.27M |
|
255
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.32B
| $16.5M | 0.09% |
349,124
-33,934
| -9% | -$1.55M |
|
|
NUVA
256
DELISTED
NuVasive, Inc.
NUVA
| $16.4M | 0.09% |
250,608
+29,426
| +13% | +$1.77M |
|
257
Simmons First National
SFNC
$3.39B
| $16.4M | 0.09% |
552,081
+21,985
| +4% | +$618K |
|
258
Nexstar Media Group
NXST
$6.01B
| $16.3M | 0.09% |
116,211
-113,289
| -49% | -$14.8M |
|
259
Eaton
ETN
$141B
| $16.3M | 0.09% |
117,899
-1,514
| -1% | -$195K |
|
260
Energizer
ENR
$1.47B
| $16.3M | 0.09% |
342,773
-89,348
| -21% | -$4.11M |
|
261
Ameris Bancorp
ABCB
$5.89B
| $16.1M | 0.09% |
307,489
-80,092
| -21% | -$3.81M |
|
262
Stewart Information Services
STC
$2.14B
| $15.9M | 0.09% |
304,931
+155,773
| +104% | +$7.91M |
|
263
Neogen
NEOG
$2.05B
| $15.8M | 0.09% |
356,368
-89,370
| -20% | -$3.75M |
|
264
Radian Group
RDN
$5.28B
| $15.8M | 0.09% |
680,607
-174,601
| -20% | -$3.72M |
|
265
TE Connectivity
TEL
$60B
| $15.8M | 0.09% |
122,548
+37,411
| +44% | +$4.81M |
|
266
Raymond James Financial
RJF
$33.5B
| $15.8M | 0.09% |
192,935
+180,305
| +1,428% | +$13.4M |
|
|
NLSN
267
DELISTED
Nielsen Holdings plc
NLSN
| $15.7M | 0.08% |
+623,632
| New | +$14.7M |
|
268
Boise Cascade
BCC
$2.73B
| $15.6M | 0.08% |
260,323
-68,413
| -21% | -$3.61M |
|
269
LXP Industrial Trust
LXP
$3.52B
| $15.6M | 0.08% |
280,383
-80,261
| -22% | -$4.34M |
|
270
Dycom Industries
DY
$11.2B
| $15.5M | 0.08% |
167,088
-43,527
| -21% | -$3.77M |
|
271
Graphic Packaging
GPK
$3.35B
| $15.4M | 0.08% |
847,112
-220,470
| -21% | -$3.76M |
|
272
LCI Industries
LCII
$2.59B
| $15.3M | 0.08% |
115,919
-31,350
| -21% | -$4.38M |
|
273
Supernus Pharmaceuticals
SUPN
$2.7B
| $14.9M | 0.08% |
569,461
+77,727
| +16% | +$2.17M |
|
274
CarGurus
CARG
$3.34B
| $14.9M | 0.08% |
+625,167
| New | +$18.1M |
|
275
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $14.9M | 0.08% |
286,015
+3,785
| +1% | +$189K |
|
Similar funds
EWA
MIC
P
OSAM
CB
EIM
SC
Glenmede Trust's Q1 2021 Portfolio in Review
As of Q1 2021, Glenmede Trust held 1,286 positions worth $18.6B, up 2% from $18.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Glenmede Trust withdrew a net $1.05B in Q1 2021, closing 90 positions and reducing 580 holdings. Its most notable exit was Coherent, an estimated $32.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in Rollins worth $29.6M.
- Glenmede Trust's largest Q1 2021 buy was Rollins: 860,755 shares worth $29.6M.
- Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $42.1M increase.
- Glenmede Trust's biggest Q1 2021 reduction was Progressive, cutting an estimated $132M.
- Glenmede Trust fully exited Coherent in Q1 2021, selling an estimated $32.9M.
- Glenmede Trust's ten largest holdings make up 20% of its $18.6B portfolio in Q1 2021.
- Glenmede Trust opened 95 new positions and closed 90 in Q1 2021.
- Glenmede Trust's portfolio value rose 2% quarter-over-quarter to $18.6B.
Based on Glenmede Trust's 13F filing for Q1 2021, filed 18 May 2021.